Is Saw Palmetto a Diuretic? Effects on Urination

Saw palmetto is not a diuretic in any meaningful pharmacological sense. It does not increase urine production or cause your kidneys to flush extra water and salt from your body the way actual diuretics do. Its reputation as a diuretic comes from a long history of traditional use for urinary complaints, but the way it affects urination has nothing to do with how diuretics work.

Why Saw Palmetto Gets Called a Diuretic

The confusion is understandable. Saw palmetto has been used for centuries to treat urinary problems like frequent urination, weak urine flow, and waking up at night to pee. Older herbal references describe it as having “diuretic, urinary antiseptic, and anabolic properties.” When something changes how often or how easily you urinate, it’s natural to assume it’s acting like a water pill. But the mechanism is entirely different.

True diuretics work on the kidneys. They block the reabsorption of sodium, which pulls water into the urine and increases total urine output. This is why diuretics can cause dehydration, low potassium, and electrolyte imbalances. Saw palmetto doesn’t do any of this. A safety study that tracked lab values in men taking saw palmetto for over a year found no clinically meaningful changes in electrolytes compared to placebo. There was a small statistical difference in potassium levels, but not the kind of depletion you’d see with an actual diuretic.

How Saw Palmetto Actually Affects Urination

Saw palmetto’s urinary effects are tied to the prostate, not the kidneys. Its active compounds are primarily fatty acids (oleic, lauric, myristic, and palmitic acid) that appear to interfere with the hormonal signals driving prostate growth. Specifically, these compounds reduce the conversion of testosterone into a more potent hormone called DHT, which is a key driver of prostate enlargement. They also block the prostate from taking up testosterone and DHT as readily, and they reduce estrogen receptor activity in prostate tissue.

When the prostate enlarges, it squeezes the urethra and makes it harder to empty the bladder fully. This leads to the classic symptoms of benign prostatic hyperplasia (BPH): weak stream, frequent urination, and nighttime bathroom trips. By potentially reducing prostate tissue growth, saw palmetto could ease that mechanical obstruction. The extract also appears to have anti-inflammatory and antispasmodic effects on the bladder muscle, which may help reduce the urgency and frequency that come with an irritated bladder.

So if saw palmetto helps someone urinate more easily, it’s not because more urine is being produced. It’s because the urine that’s already there can flow out with less obstruction.

Does It Actually Work for Urinary Symptoms?

This is where the picture gets complicated. Earlier reviews of saw palmetto research were fairly positive. One systematic review found that saw palmetto extracts improved urinary symptom scores compared with placebo, and some studies showed improvements in peak urine flow rate and reductions in nighttime urination. A head-to-head trial even found no significant difference between saw palmetto and the prescription alpha-blocker tamsulosin in symptom scores or flow rate after one year. Another systematic review found it performed comparably to finasteride, a common prescription medication for BPH.

More recent and rigorous research, however, has been less encouraging. A randomized trial of 369 men with BPH tested saw palmetto at escalating doses, starting at 320 mg per day, then doubling to 640 mg, and finally tripling to 960 mg per day. After 72 weeks, there were no significant differences between the saw palmetto group and the placebo group in nighttime urination frequency, peak urine flow rate, or the amount of urine left in the bladder after voiding. Even at three times the standard dose, the extract showed no measurable benefit over a sugar pill.

This doesn’t necessarily mean saw palmetto is useless for every individual, but it does mean the evidence is inconsistent. The earlier positive studies often used specific branded extracts, and product quality varies enormously across the supplement market. What you buy at a pharmacy may not contain the same concentration of active fatty acids as what was tested in a clinical trial.

Saw Palmetto vs. Prescription BPH Medications

Prescription medications for BPH fall into two categories. Alpha-blockers like tamsulosin relax the smooth muscle around the prostate and bladder neck, making it physically easier for urine to pass through. They work within days to weeks but don’t shrink the prostate itself. Medications like finasteride block the same testosterone-to-DHT conversion that saw palmetto targets, but they do it far more potently and consistently, typically reducing prostate volume by about 20 to 30 percent over several months.

Saw palmetto’s proposed mechanism overlaps with finasteride’s, but the effect size appears much smaller and less reliable. Neither saw palmetto nor these prescription drugs are diuretics. They all work by either relaxing tissue or reducing prostate size to improve flow, not by increasing urine production. If you’re taking an actual diuretic for blood pressure or fluid retention and wondering whether saw palmetto will compound that effect, the answer based on current evidence is no. It operates through a completely separate pathway and does not appear to cause the fluid or electrolyte shifts characteristic of diuretic medications.

What This Means Practically

If you’re experiencing frequent urination or difficulty emptying your bladder, saw palmetto is unlikely to make you urinate more. It’s not pulling extra water through your kidneys, and at best it may modestly ease the mechanical obstruction caused by an enlarged prostate. You won’t need to worry about dehydration or electrolyte loss the way you would with a true diuretic like hydrochlorothiazide or furosemide.

The standard dose used in most studies is 320 mg per day of a liposterolic extract. Products vary widely in quality, so a standardized extract from a reputable manufacturer is more likely to contain the fatty acid profile that’s been studied. Even so, the most rigorous clinical trial available found no benefit at doses up to three times that amount, so expectations should be realistic.